Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain

European Journal of Pharmacology

Volumn 399, Issue 2-3, 2000, Pages 131-139

  Esser, Michael J ^a   Sawynok, Jana ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Amitriptyline; Caffeine; Neuropathic pain; Thermal hyperalgesia

Indexed keywords

AMITRIPTYLINE; CAFFEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNULA; CONTROLLED STUDY; DRUG DOSE; HYPERALGESIA; MALE; NEURALGIA; NONHUMAN; PRIORITY JOURNAL; RAT; TECHNIQUE;

AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INJECTIONS, SPINAL; LIGATION; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES;

EID: 0034617384     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00336-8     Document Type: Article

References (38)

1. Barone J.J., Roberts H.R. Caffeine consumption. Fd. Chem. Toxic. 34(1):1996;119-129.
2. Belfrage M., Sollevi A., Segerdahl M., Sjölund K.-F., Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth. Analg. 81:1995;713-717.
3. Chaplan S.R., Malmberg A.B., Yaksh T.L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. JPET. 280:1997;829-838.
4. Cui J.-C., Sollevi A., Linderoth B., Meyerson B.A. Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats. Neurosci. Lett. 223:1997;173-176.
5. Eisenach J., Gebhart G.F. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology. 83:1995;1046-1054.
6. Eisenach J., Gebhart G.F. Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats. Anesthesiology. 83:1995;1036-1045.
7. Eschalier A., Mestre C., Dubrya C., Ardid D. Why are antidepressants effective as pain relief? CNS Drugs. 2:1994;261-267.
8. Eschalier A., Ardid D., Dubray C. Tricyclic and other antidepressants as analgesics. Sawynok J., Cowan A. Novel Aspects of Pain Management: Opioids and Beyond. 1999;303-320 Wiley, New York, NY.
9. Esser M.J., Sawynok J. Caffeine inhibits the thermal antihyperalgesic effect of amitriptyline in a rat model of neuropathic pain. Drug Dev. Res. 43:1998;54.
10. Esser M.J., Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain. 80:1999;643-653.
11. Fredholm B.R. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76:1995;93-101.
12. Gilbert R.M. Caffeine consumption. Prog. Clin. Biol. Res. 158:1984;185-213.
13. Guieu R., Peragut J.C., Roussel P., Hassani H., Sampieri F., Bechis G., Gola R., Rochat H. Adenosine and neuropathic pain. Pain. 68:1996;271-274.
14. Hargreaves K., Dubner R., Brown F., Flores C., Jores L.A. New and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
15. Hwang A.S., Wilcox G.L. Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain. 28:1987;343-355.
16. Khandwala H., Zhang Z., Loomis C.W. Inhibition of strychnine-allodynia is mediated by spinal adenosine A1 - but not A2-receptors in the rat. Brain Res. 808:1998;106-109.
17. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
18. Lee Y.W., Yaksh T.L. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. JPET. 27:1996;1642-1648.
19. 1 receptor agonists in a rat neuropathic pain model. Neurosci. Abs. 24:1998;1630.
20. Mao J., Mayer D.J., Hayes R.L., Lu J., Price D.D. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598:1992;271-278.
21. Mao J., Price D.D., Coghill R.C., Mayer D.J., Hayes R.L. Intrathecal MK-801 and local nerve anaesthesia synergistically reduce nociceptive behaviours in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
22. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J., Frenk A. Intrathecal treatment with dextrophan or ketamine potently reduces pain-related behaviours in a rat model of peripheral mononeuropathy. Brain Res. 605:1993;164-168.
23. MacFarlane B.V., Wright A., O'Callaghan J., Benson H.A.E. Chronic neuropathic pain and its control by drugs. Pharmacol. Ther. 75:1997;1-19.
24. McQuay H.L., Tramer M., Nye B.A., Carroll D., Wiffen P.J., Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227.
25. Nehlig A., Daval J.-L., Derby G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psycostimulat effects. Brain Res. Rev. 17:1992;139-170.
26. Pareek S.S., Chopde C.T., Thakur Desai P.A. Adenosine enhances analgesic effect of tricyclic antidepressants. Ind. J. Pharmacol. 26:1994;159-161.
27. Phillis J.W. Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants. Br. J. Pharmacol. 83:1984;567-575.
28. Phillis J.W., Wu P.H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp. Biochem. Physiol. C. 72:1982;179-187.
29. Rane K., Segerdahl M., Goiny M., Sollevi A. Intrathecal adenosine administration. A phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology. 89:1998;1108-1115.
30. Sawynok J., Reid A. Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine administered in various sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;1-8.
31. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 317:1998;1-11.
32. Sawynok J., Reid A., Esser M.J. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain. 80:1999;45-55.
33. Sierralta F., Pinardi G., Mendez M., Miranda H.F. Interaction of opioids with antidepressant-induced antinociception. Psychopharmacol. Berl. 122:1995;374-378.
34. Sjölund K.F., Sollevi A., Segerdahl M., Hansson P., Lundberg T. Intrathecal and systemic R-phenylisopropyl-adenosine reduces scratching behaviour an a rat mononeuropathy model. NeuroReport. 7:1996;1856-1860.
35. Sollevi A., Belfrage M., Lundeberg T., Segerdahl M., Hansson P. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain. 61:1995;155-158.
36. Sosnowski M., Yaksh T.L. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth. Analg. 69:1989;587-592.
37. Yamamoto T., Yaksh T.L. Spinal pharmacology of thermal hyperalgesia induced by constriction injury of sciatic nerve: excitatory amino acid antagonists. Pain. 49:1992;121-128.
38. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-111.